514 related articles for article (PubMed ID: 25400825)
1. Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.
Lu QY; Chen W; Lu L; Zheng Z; Xu X
Int J Clin Exp Pathol; 2014; 7(10):7268-77. PubMed ID: 25400825
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T
PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
[TBL] [Abstract][Full Text] [Related]
3. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT
FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
[TBL] [Abstract][Full Text] [Related]
4. High Glucose Aggravates Retinal Endothelial Cell Dysfunction by Activating the RhoA/ROCK1/pMLC/Connexin43 Signaling Pathway.
Zhao H; Kong H; Wang W; Chen T; Zhang Y; Zhu J; Feng D; Cui Y
Invest Ophthalmol Vis Sci; 2022 Jul; 63(8):22. PubMed ID: 35881407
[TBL] [Abstract][Full Text] [Related]
5. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
6. RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.
Lu Q; Lu L; Chen W; Chen H; Xu X; Zheng Z
Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):669-80. PubMed ID: 25791356
[TBL] [Abstract][Full Text] [Related]
7. Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.
Mangialardi G; Katare R; Oikawa A; Meloni M; Reni C; Emanueli C; Madeddu P
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):555-64. PubMed ID: 23307872
[TBL] [Abstract][Full Text] [Related]
8. High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway.
Cheng CI; Chen PH; Lin YC; Kao YH
Cell Signal; 2015 Feb; 27(2):283-92. PubMed ID: 25446262
[TBL] [Abstract][Full Text] [Related]
9. Arctiin attenuates high glucose-induced human retinal capillary endothelial cell proliferation by regulating ROCK1/PTEN/PI3K/Akt/VEGF pathway in vitro.
Zhou M; Li G; Zhu L; Zhou H; Lu L
J Cell Mol Med; 2020 May; 24(10):5695-5706. PubMed ID: 32297701
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
11. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton.
Yang L; Tang L; Dai F; Meng G; Yin R; Xu X; Yao W
Toxicology; 2017 Aug; 389():74-84. PubMed ID: 28743511
[TBL] [Abstract][Full Text] [Related]
12. Rutin Prevents High Glucose-Induced Renal Glomerular Endothelial Hyperpermeability by Inhibiting the ROS/Rhoa/ROCK Signaling Pathway.
Wang X; Zhao X; Feng T; Jin G; Li Z
Planta Med; 2016 Sep; 82(14):1252-7. PubMed ID: 27552253
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Jun HO; Yu YS; Kim KW
Am J Pathol; 2010 Mar; 176(3):1517-24. PubMed ID: 20110406
[TBL] [Abstract][Full Text] [Related]
14. A Positive Feedback Loop of Profilin-1 and RhoA/ROCK1 Promotes Endothelial Dysfunction and Oxidative Stress.
Li X; Liu J; Chen B; Fan L
Oxid Med Cell Longev; 2018; 2018():4169575. PubMed ID: 29849894
[TBL] [Abstract][Full Text] [Related]
15. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
16. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
Xu XT; Song QB; Yao Y; Ruan P; Tao ZZ
Hepatogastroenterology; 2012; 59(120):2523-6. PubMed ID: 22584506
[TBL] [Abstract][Full Text] [Related]
18. S1PR2 antagonist ameliorate high glucose-induced fission and dysfunction of mitochondria in HRGECs via regulating ROCK1.
Chen W; Xiang H; Chen R; Yang J; Yang X; Zhou J; Liu H; Zhao S; Xiao J; Chen P; Chen AF; Chen S; Lu H
BMC Nephrol; 2019 Apr; 20(1):135. PubMed ID: 30999892
[TBL] [Abstract][Full Text] [Related]
19. Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA/ROCK signaling pathway.
Yin Q; Xia Y; Wang G
Biochem Biophys Res Commun; 2016 Sep; 477(4):881-886. PubMed ID: 27378427
[TBL] [Abstract][Full Text] [Related]
20. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
